KPRX
Kiora Pharmaceuticals Inc
NASDAQ · Pharmaceuticals
$2.15
+0.03 (+1.42%)
Open$2.13
Previous Close$2.12
Day High$2.18
Day Low$2.10
52W High$24.46
52W Low$15.91
Volume—
Avg Volume737.0K
Market Cap7.91M
P/E Ratio23.11
EPS$1.00
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,264.7% upside
Current
$2.15
$2.15
Target
$29.34
$29.34
$16.75
$29.34 avg
$32.13
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.02M | 1.95M | 2.03M |
| Net Income | 297.3K | 336.4K | 321.2K |
| Profit Margin | 14.7% | 17.3% | 15.8% |
| EBITDA | 553.0K | 564.5K | 565.8K |
| Free Cash Flow | 382.2K | 437.5K | 326.8K |
| Rev Growth | +18.3% | -4.0% | +17.8% |
| Debt/Equity | 0.98 | 0.84 | 0.87 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |